Krystof Bankiewicz

About Krystof Bankiewicz

Krystof Bankiewicz, With an exceptional h-index of 84 and a recent h-index of 41 (since 2020), a distinguished researcher at University of California, San Francisco,

His recent articles reflect a diverse array of research interests and contributions to the field:

AAV2-GDNF Gene Delivery in Mild-and Moderate-Stages of Parkinson’s Disease: Preliminary Brain Imaging and Clinical Outcomes

Phase 1b Safety and Preliminary Efficacy of Bilateral Intraputaminal Delivery of AAV2 GDNF (AB-1005) in Participants With Mild or Moderate Parkinson’s Disease (N2. 001)

Real-Time Magnetic Resonance Imaging During Convective Gene Therapy Perfusion of the Brain

Validated assays for the quantification of C9orf72 human pathology

CTNI-52. SURVIVAL OUTCOMES IN RECURRENT GLIOBLASTOMA (RGBM) PATIENTS TREATED WITH A SINGLE INTRA-TUMORAL ADMINISTRATION OF BIZAXOFUSP, AN IL-4R-TARGETING TOXIN, IN A PHASE IIB …

Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes

Novel engineered capsid serotype of recombinant adeno-associated viral vector with enhanced transduction efficiency and widespread distribution in the brain

Adjustable Stepped Cannula

Krystof Bankiewicz Information

University

Position

Professor Endowed Chair

Citations(all)

22156

Citations(since 2020)

6398

Cited By

18477

hIndex(all)

84

hIndex(since 2020)

41

i10Index(all)

254

i10Index(since 2020)

155

Email

University Profile Page

Google Scholar

Top articles of Krystof Bankiewicz

Title

Journal

Author(s)

Publication Date

AAV2-GDNF Gene Delivery in Mild-and Moderate-Stages of Parkinson’s Disease: Preliminary Brain Imaging and Clinical Outcomes

Parkinsonism & Related Disorders

A Van Laar

C Christine

N Phielipp

A Merola

JB Elder

...

2024/5/1

Phase 1b Safety and Preliminary Efficacy of Bilateral Intraputaminal Delivery of AAV2 GDNF (AB-1005) in Participants With Mild or Moderate Parkinson’s Disease (N2. 001)

Amber Van Laar

Chadwick Christine

Aristide Merola

Nicolás Phielipp

Bradley Elder

...

2024/4/14

Real-Time Magnetic Resonance Imaging During Convective Gene Therapy Perfusion of the Brain

JAMA surgery

Asad S Akhter

Krzysztof S Bankiewicz

Russell R Lonser

2024/1/10

Validated assays for the quantification of C9orf72 human pathology

Scientific Reports

SE Salomonsson

AM Maltos

K Gill

O Aladesuyi Arogundade

KA Brown

...

2024/1/8

CTNI-52. SURVIVAL OUTCOMES IN RECURRENT GLIOBLASTOMA (RGBM) PATIENTS TREATED WITH A SINGLE INTRA-TUMORAL ADMINISTRATION OF BIZAXOFUSP, AN IL-4R-TARGETING TOXIN, IN A PHASE IIB …

Neuro-Oncology

John Sampson

Achal Singh Achrol

Manish Aghi

Krystof Bankiewicz

Martin Bexon

...

2023/11/1

Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes

Neurology

Chadwick W Christine

R Mark Richardson

Amber Van Laar

Elisabeth M Fine

Omar S Khwaja

...

2022/8/9

Novel engineered capsid serotype of recombinant adeno-associated viral vector with enhanced transduction efficiency and widespread distribution in the brain

2023/10/19

Adjustable Stepped Cannula

2023/8/24

GDNF gene therapy for alcohol use disorder in male non-human primates

Nature medicine

Matthew M Ford

Brianna E George

Victor S Van Laar

Katherine M Holleran

Jerusha Naidoo

...

2023/8

Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial

Neuro-oncology

John H Sampson

Achal Singh Achrol

Manish K Aghi

Krystof Bankiewicz

Martin Bexon

...

2023/6/1

Efficacy of convection enhanced delivery of MTX110 (soluble panobinostat) in preclinical Diffuse Intrinsic Pontine Glioma models using metabolic hyperpolarized 13C imaging

EJC Paediatric Oncology

Justyna M Przystal

Ilwoo Park

Jie Zhang

Piotr Hadaczek

Krystof Bankiewicz

...

2023/12/1

Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson’s disease

Molecular Therapy

Matthew T Rocco

Asad S Akhter

Debra J Ehrlich

Gretchen C Scott

Codrin Lungu

...

2022/12/7

Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders

2022/11/3

A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time imaging with gadolinium in patients with recurrent high grade glioma

Brain Tumor Research and Treatment

Nicholas Butowski

Manish Aghi

Mitch Berger

Krys Bankiewicz

Jennifer Clarke

...

2022/3/15

Safety of AADC gene therapy for moderately advanced Parkinson disease: three-year outcomes from the PD-1101 trial

Neurology

Chadwick W Christine

R Mark Richardson

Amber D Van Laar

Marin E Thompson

Elisabeth M Fine

...

2022/1/4

Methods for Biomedical Targeting and Delivery and Devices and Systems for Practicing the Same

2022/9/22

Trajectory array guide system

2022/11/15

An update on gene therapy approaches for Parkinson’s disease: restoration of dopaminergic function

Amber D Van Laar

Victor S Van Laar

Waldy San Sebastian

Aristide Merola

J Bradley Elder

...

2021/1/1

Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons

Nature communications

Toni S Pearson

Nalin Gupta

Waldy San Sebastian

Jill Imamura-Ching

Amy Viehoever

...

2021/7/12

Safety assessment of AAV2-hGDNF administered via intracerebral injection in rats for treatment of Parkinson's disease

International journal of toxicology

Pramod S Terse

Adrian P Kells

Patricia Noker

J Fraser Wright

Krystof S Bankiewicz

2021/1

See List of Professors in Krystof Bankiewicz University(University of California, San Francisco)